Zdrowie i gospodarka · 07/06/2021
FDA Clears ATROVENT Metered Spray for Continued Sale
The US Food and Drug Administration (FDA) has ruled that ATROVENT (ipratropium bromide) metered spray, 0.021 mcg/spray and 0.042 mcg/spray, were not withdrawn from sale due to safety or effectiveness concerns, allowing the drug to remain on the market.